ArticleFrontiers in pharmacology2024

Wnt/β-catenin pathway as a potential target for Parkinson's disease: a cohort study of romosozumab using routinely collected health data in Japan.

Shoichiro Inokuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.